Julie E. Bauman, MD, MPH ...

Dr. Julie Bauman, MD

Claim this profile

George Washington University Medical Center

Studies Squamous Cell Carcinoma
Studies Oropharyngeal Carcinoma
7 reported clinical trials
12 drugs studied

Area of expertise

1Squamous Cell Carcinoma
Julie Bauman, MD has run 4 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
p16 negative
HPV negative
Stage III
2Oropharyngeal Carcinoma
Julie Bauman, MD has run 4 trials for Oropharyngeal Carcinoma. Some of their research focus areas include:
p16 negative
HPV positive
p16 positive

Affiliated Hospitals

Image of trial facility.
George Washington University Medical Center
Image of trial facility.
University Of Arizona Cancer Center - Prevention Research Clinic

Clinical Trials Julie Bauman, MD is currently running

Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
Image of trial facility.

Broccoli Extract

for Tobacco-Related Cancer Risk

This trial tests if an extract from broccoli seeds and sprouts can help heavy smokers by removing harmful substances from their bodies and protecting their cells from damage. Sulforaphane, derived from broccoli seeds and sprouts, has been shown to induce detoxification enzymes and protect against cancer.
Recruiting0 awards Phase 213 criteria

More about Julie Bauman, MD

Clinical Trial Related6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Julie Bauman, MD has experience with
  • Nivolumab
  • Cisplatin
  • Intensity-Modulated Radiation Therapy
  • Broccoli Sprout/Broccoli Seed Extract Supplement
  • Abemaciclib
  • Cemiplimab-Rwlc

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Julie Bauman, MD specialize in?
Is Julie Bauman, MD currently recruiting for clinical trials?
Are there any treatments that Julie Bauman, MD has studied deeply?
What is the best way to schedule an appointment with Julie Bauman, MD?
What is the office address of Julie Bauman, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security